文献速递慢性肾脏病遗传性与小管间质肾病

C5a抑制可调节脂代谢并减轻糖尿病肾病小管间质纤维化

Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究探讨补体C5a/C5aR信号在糖尿病肾病(DN)中的作用及C5a抑制的治疗潜力。人肾活检显示DN患者肾小管C5a水平升高且与疾病进展正相关;db/db小鼠中C5a抑制剂NOX-D21降低血清甘油三酯、改善肾功能并减少小管间质损伤和纤维化;HK-2细胞中C5a通过PI3K/Akt通路刺激TGF-β产生。

要点

  • DN患者肾小管C5a表达升高且与疾病进展正相关
  • C5a抑制剂NOX-D21降低db/db小鼠血清甘油三酯并减少肾脏脂质积累
  • NOX-D21减轻糖尿病肾脏小管间质纤维化并改善肾功能

核心结论

  • 阻断C5a信号通过NOX-D21可调节糖尿病中的脂代谢异常,并通过减少脂质积累和TGF-β驱动的纤维化改善糖尿病肾脏小管间质纤维化。

研究设计与样本

  • 研究纳入DN患者和对照者肾活检组织进行补体C5成分免疫组化染色。
  • 比较db/m小鼠、溶剂处理的db/db小鼠和C5a抑制剂NOX-D21处理的db/db小鼠的肾功能和小管间质损伤。
  • 使用肾小管上皮细胞(HK-2)培养模型展示C5a对肾脏纤维化通路的影响。

主要发现

  • DN患者肾小管中C5a水平升高,但未检测到其受体C5aR水平升高,且C5a染色强度与疾病进展正相关。
  • 在db/db小鼠中,NOX-D21降低血清甘油三酯水平,减弱二酰甘油酰基转移酶-1和固醇调节元件结合蛋白-1表达上调及糖尿病肾脏脂质积累。
  • NOX-D21处理的糖尿病小鼠血清尿素氮和肌酐水平降低,肾小球和小管间质损伤减轻。
  • NOX-D21减少肾脏转化生长因子β1(TGF-β1)、纤连蛋白和I型胶原表达。
  • 在HK-2细胞中,C5a通过激活PI3K/Akt信号通路刺激TGF-β产生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complement C5 mediates pro-inflammatory responses in many immune-related renal diseases. Given that the C5a level is elevated in diabetes, we investigated whether activation of C5a/C5aR signalling plays a pathogenic role in diabetic nephropathy (DN) and the therapeutic potential of C5a inhibition for renal fibrosis. METHODS: Human renal biopsies from patients with DN and control subjects were used for immunohistochemical staining of complement C5 components. Renal function and tubulointerstitial injury were compared between db/m mice, vehicle-treated mice and C5a inhibitor-treated db/db mice. A cell culture model of tubule epithelial cells (HK-2) was used to demonstrate the effect of C5a on the renal fibrotic pathway. RESULTS: Increased levels of C5a, but not of its receptor C5aR, were detected in renal tubules from patients with DN. The intensity of C5a staining was positively correlated with the progression of the disease. In db/db mice, administration of a novel C5a inhibitor, NOX-D21, reduced the serum triglyceride level and attenuated the upregulation of diacylglycerolacyltransferase-1 and sterol-regulatory element binding protein-1 expression and lipid accumulation in diabetic kidney. NOX-D21-treated diabetic mice also had reduced serum blood urea nitrogen and creatinine levels with less glomerular and tubulointerstitial damage. Renal transforming growth factor beta 1 (TGF-β1), fibronectin and collagen type I expressions were reduced by NOX-D21. In HK-2 cells, C5a stimulated TGF-β production through the activation of the PI3K/Akt signalling pathway. CONCLUSIONS: Blockade of C5a signalling by NOX-D21 moderates altered lipid metabolism in diabetes and improved tubulointerstitial fibrosis by reduction of lipid accumulation and TGF-β-driven fibrosis in diabetic kidney.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Yiu WH, Li RX, Wong DWL, et al. Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy. Nephrol Dial Transplant. 2018. PMID: 29294056. doi:10.1093/ndt/gfx336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。